1. Home
  2. IQV vs HEI Comparison

IQV vs HEI Comparison

Compare IQV & HEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • HEI
  • Stock Information
  • Founded
  • IQV 1982
  • HEI 1957
  • Country
  • IQV United States
  • HEI United States
  • Employees
  • IQV N/A
  • HEI N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • HEI Aerospace
  • Sector
  • IQV Health Care
  • HEI Industrials
  • Exchange
  • IQV Nasdaq
  • HEI Nasdaq
  • Market Cap
  • IQV 35.7B
  • HEI 33.2B
  • IPO Year
  • IQV 2013
  • HEI N/A
  • Fundamental
  • Price
  • IQV $190.98
  • HEI $225.56
  • Analyst Decision
  • IQV Strong Buy
  • HEI Buy
  • Analyst Count
  • IQV 17
  • HEI 11
  • Target Price
  • IQV $251.00
  • HEI $270.20
  • AVG Volume (30 Days)
  • IQV 1.4M
  • HEI 456.3K
  • Earning Date
  • IQV 02-06-2025
  • HEI 02-26-2025
  • Dividend Yield
  • IQV N/A
  • HEI 0.10%
  • EPS Growth
  • IQV 2.74
  • HEI 26.12
  • EPS
  • IQV 7.49
  • HEI 3.67
  • Revenue
  • IQV $15,405,000,000.00
  • HEI $3,857,669,000.00
  • Revenue This Year
  • IQV $5.17
  • HEI $10.66
  • Revenue Next Year
  • IQV $6.04
  • HEI $7.17
  • P/E Ratio
  • IQV $25.51
  • HEI $61.76
  • Revenue Growth
  • IQV 2.81
  • HEI 29.97
  • 52 Week Low
  • IQV $187.62
  • HEI $182.47
  • 52 Week High
  • IQV $261.73
  • HEI $283.60
  • Technical
  • Relative Strength Index (RSI)
  • IQV 37.76
  • HEI 40.45
  • Support Level
  • IQV $192.10
  • HEI $216.68
  • Resistance Level
  • IQV $198.90
  • HEI $238.47
  • Average True Range (ATR)
  • IQV 5.43
  • HEI 5.40
  • MACD
  • IQV -1.28
  • HEI -0.55
  • Stochastic Oscillator
  • IQV 0.75
  • HEI 33.82

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About HEI Heico Corporation

Heico is an aerospace and defense supplier that focuses on creating niche replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates as two segments: the flight support group,or FSG, and the electronic technologies group, or ETG, both of which supply the aerospace and defense sectors to different degrees. The company is persistently acquisitive, focusing on companies in similar or adjacent markets that are generating strong cash flow and profitable growth potential.

Share on Social Networks: